Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Trading Statement

17 Jul 2019 07:00

RNS Number : 7410F
Galliford Try PLC
17 July 2019
 

 

GALLIFORD TRY PLC

 

TRADING UPDATE

WEDNESDAY 17 JULY 2019

 

Galliford Try plc, the housebuilding, regeneration and construction group, today provides the following update on trading for the year ended 30 June 2019. All data is as at 30 June 2019, unless otherwise stated, and all comparatives relate to the prior year equivalent period. The Group expects to announce its results for the full year on 11 September 2019.

 

Group

· The Group continues to trade well and expects to report full year profit before tax in line with the current range of analysts' expectations1.

· Full year result to include £40m of previously reported exceptional items2.

· Linden Homes has maintained its sales rate and strong margin and continues to improve its customer satisfaction.

· Partnerships & Regeneration continues to achieve strong growth ahead of targets, increasing both revenues and margins, and successfully completing the acquisition of the Strategic Team Group in Yorkshire.

· The strategic review of Construction is now complete, and underlying operations are performing well.

· Net debt at 30 June 2019 of £60m (2018: net cash £98m) with average net debt of £187m, in line with previous guidance for the full year.

 

Linden Homes

Linden Homes has maintained its good performance and strong margin and remains a four-star housebuilder.

 

The sales rate for the year ended 30 June 2019 was 0.56 per site per week from an average of 80 outlets (2018: 0.59 and 85). Linden Homes delivered 3,229 unit completions, including units in joint ventures (2018: 3,442 units), at an average private selling price of £351,000 (2018: £367,000), continuing to reflect our refocus on mid-range family houses in The Linden Collection and reduced exposure in central London. We have a strong carried forward position of 2,564 year end units (2018: 2,326) representing a value of £375m (2018: £366m). Linden Homes' landbank increased to 11,900 plots (2018: 11,400 plots), with all plots secured for the new financial year and 85% of plots secured for FY2021.

 

Partnerships & Regeneration

Partnerships & Regeneration made further excellent progress against its strategy of increasing geographic coverage and growing margins. At 30 June 2019 the business has a £1.0bn contracting order book (2018: £1.2bn) and mixed-tenure sales carried forward of £184m (2018: £160m). The landbank has increased by 61% to 5,300 plots (2018: 3,300 plots).

 

On 1 July 2019 we were delighted to complete the acquisition of Strategic Team Group (STG), giving us a mature operating platform in Yorkshire and expanding our presence in Cheshire. STG is a well-established regional business with 120 employees and a revenue in its last full year of circa £60m.

 

Construction

The restructure of our Construction business is complete, and the business is refocused to deliver an improved future performance. The result for the year includes contract write-downs and restructuring costs previously announced2.

 

The Aberdeen Western Peripheral Route is complete and delivering economic benefits to the region and receiving a positive reaction from all stakeholders. The joint venture continues to negotiate on the significant claim with the client, while preparing to pursue this through formal dispute resolution should these talks not reach a satisfactory conclusion.

 

The current order book is £2.9bn (2018: £3.3bn) with 88% of revenue for the new financial year secured (2018: 87%).

 

Graham Prothero, Chief Executive, commented:

 

"The Group has continued to perform well, supported by good housing demand. We expect our full year results and average net debt to be in line with previous guidance.

 

We are making strong progress against the operational targets we set out in 2017. We are reviewing our 2021 volume targets to ensure that growth is controlled, and our gearing is managed. Despite the weaker economic outlook, Linden Homes continues to see robust demand, with operating efficiencies driving strong margins and improving customer satisfaction. Partnerships & Regeneration is well on track with its aspirations for exciting growth in both revenue and margins, with some key wins in the period and further good opportunities across the market. We are pleased that the restructure of the Construction business is now complete. The business is now firmly focused on its core strengths of regional building operations, together with profitable operations in highways and water, all of which are now performing effectively. I look forward to the next financial year with the appropriate strategic priorities in place across the Group."

 

A conference call for Analysts and Investors will be held at 09:00am today (UK time).

 

UK dial-in: +44 20 3936 2999

US dial-in: +1 646 664 1960

 

Participant PIN: 006063

 

For further enquiries please contact:

 

 

Galliford Try

Graham Prothero, Chief Executive

01895 855001

 

Andrew Duxbury, Finance Director

 

 

 

 

Tulchan Communications

James Macey White

Martin Pengelley

Elizabeth Snow

020 7353 4200

 

 

Galliford Try is listed on the London Stock Exchange and is a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure projects with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2018, the Group generated revenue of £3.1bn.

 

1. The company compiled range of analysts' forecasts for profit before tax after taking into account exceptional items for the year ending 30 June 2019 is £112.7m to £116.4m based on forecasts as at 16 July 2019.

 

2. Exceptional items of £40m recognised in the year include £30.4m reported in the half year to 31 December 2018 and £10m arising from the reorganisation costs and write-downs reported in our Trading Statement on 21 May 2019. The remaining £30m write-down reported on 21 May 2019 has been recognised in operating costs.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFVEDDIRLIA
Date   Source Headline
12th Sep 20187:00 amRNSFinal Results
4th Sep 201810:00 amRNSHolding(s) in Company
3rd Sep 20189:00 amRNSConfirmation of Directorate Change
21st Aug 201812:00 pmRNSHolding(s) in Company
1st Aug 20182:00 pmRNSTotal Voting Rights
24th Jul 20184:00 pmRNSHolding(s) in Company
19th Jul 201811:00 amRNSDirectorate Change
17th Jul 20187:00 amRNSTrading Statement
11th Jul 201812:00 pmRNSHolding(s) in Company
2nd Jul 201812:00 pmRNSTotal Voting Rights
27th Jun 20182:00 pmRNSBlock listing Interim Review
7th Jun 201810:00 amRNSDirector/PDMR Shareholding
5th Jun 20182:00 pmRNSDirector/PDMR Shareholding
1st Jun 201812:00 pmRNSTotal Voting Rights
25th May 201812:00 pmRNSDirector/PDMR Shareholding
22nd May 20187:00 amRNSTrading Statement
9th May 20184:00 pmRNSHolding(s) in Company
1st May 20184:00 pmRNSTotal Voting Rights
18th Apr 201812:00 pmRNSTotal Voting Rights
16th Apr 20183:15 pmRNSDirector/PDMR Shareholding
16th Apr 20182:43 pmRNSSuccessful Placing of Rights Issue Rump
16th Apr 20188:15 amRNSTotal Voting Rights
16th Apr 20187:25 amRNSResults of Rights Issue
9th Apr 20184:30 pmRNSDirector/PDMR Shareholding
6th Apr 20184:30 pmRNSHolding(s) in Company
6th Apr 201810:00 amRNSHolding(s) in Company
5th Apr 201810:30 amRNSDirector/PDMR Shareholding
3rd Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:00 pmRNSDirector/PDMR Shareholding
3rd Apr 201811:00 amRNSHolding(s) in Company
3rd Apr 201811:00 amRNSTotal Voting Rights
28th Mar 20182:30 pmRNSDirector/PDMR Shareholding
28th Mar 201811:00 amRNSDirector/PDMR Shareholding
27th Mar 20181:11 pmRNSPublication of Prospectus
27th Mar 20187:00 amRNSAnnouncement re: Rights Issue
20th Mar 201810:00 amRNSHolding(s) in Company
1st Mar 201812:00 pmRNSTotal Voting Rights
1st Mar 201810:00 amRNSHolding(s) in Company
14th Feb 20187:00 amRNSFully Underwritten £150 million Capital Raising
14th Feb 20187:00 amRNSHalf-year Report
5th Feb 201810:00 amRNSHolding(s) in Company
1st Feb 201812:00 pmRNSTotal Voting Rights
15th Jan 201811:04 amRNSJoint Venture with Carillion plc
2nd Jan 201812:00 pmRNSTotal Voting Rights
5th Dec 20173:00 pmRNSBlock Listing Application
4th Dec 201710:00 amRNSHolding(s) in Company
1st Dec 201712:00 pmRNSTotal Voting Rights
27th Nov 201712:00 pmRNSBlock listing Interim Review
17th Nov 201710:00 amRNSHolding(s) in Company
16th Nov 20177:00 amRNSContract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.